-The Hindu Besides the missing informal sector, over-estimation of output growth also offers clues Are the latest employment estimates by the Central Statistics Office (CSO) factually correct? No. They are off the mark, and confined to the economy’s organised or formal sector, accounting at best for 15% of the workforce. Is there a paradox in high output growth rates and the marginal effect on employment? Probably not, if one acknowledges that GDP...
More »SEARCH RESULT
Total Matching Records found : 211
Average Assets of 184 Re-Contesting Karnataka MLAs Grew by Rs 17 Crore
-TheWire.in Congress leader Siddarmaiah shows asset growth of Rs 6 crore, while BJP’s CM candidate B.S. Yeddyurappa reports a decline of Rs 1 crore, according to an ADR report. New Delhi: The average assets of the 184 re-contesting MLAs in Karnataka grew by Rs 17.31 crore, up 64%, between 2013 and 2018 from Rs 26.92 crore to Rs 44.24 crore, respectively. In fact, five Congress MLAs among these 184 saw their assets...
More »Karnataka: Tradition to the rescue -Deepthi Sanjiv
-Bangalore Mirror In Hassan, Kalyanis are being rejuvenated to get water for the parched district When she saw that her district, Hassan, was listed among the 16 permanent drought-prone districts of the state by the Central drought study committee, writer and social worker Rupa Hassan was dismayed. Rupa, who hails from Mysuru and settled in Hassan post-marriage, could not fathom how a green district that has Sakaleshpur of the Western Ghats as...
More »Private hospitals making profits of up to 1,737% on drugs, consumables and diagnostics: Study -Rema Nagarajan
-The Times of India NEW DELHI: An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on drugs, consumables and diagnostics and that these three accounts for about 46% of a patient’s bill. The analysis, released on Tuesday, noted that “the major beneficiaries of profits in all these cases because of...
More »Cardiac stent price cap lowered further to Rs 28,000 -Rema Nagarajan
-The Times of India The National Pharmaceutical Pricing Authority on Monday revised the price of drug eluting stents (DES) downwards by about Rs 2,300 to just under Rs 28,000, while marginally raising the cap on bare metal stents from Rs 7,400 to Rs 7,660. These caps are excluding GST. With DES accounting for about 95% of all stents used in India, this means most stents will become cheaper. The authority, which had...
More »
